| Document Date: 2013-03-14 12:11:16
Open Document File Size: 74,21 KBShare Result on Facebook
City Ottawa / / Company Thomson / Saskatchewan Drug Information Services / / Currency USD / / Event Product Issues / / Facility Saskatchewan Drug Information Services College of Pharmacy / / / IndustryTerm Treatment of benign prostatic hyperplasia / Treatment for BPH / treatment of choice for patients with mild symptoms / / MedicalCondition headaches / BPH / vertigo / acute urinary retention / nasal congestion / sexual dysfunction / orthostatic hypotension / less dizziness / disorder / dose syncope / benign prostatic hyperplasia / Dizziness / interoperative floppy iris syndrome 5mg Sexual dysfunction / symptomatic benign prostatic hyperplasia / / MedicalTreatment Self-Care / drug therapy / surgical treatment / / Organization American Urological Association / Saskatchewan Drug Information Services College of Pharmacy and Nutrition / / Person Melanie Cann / Carmen Bell / Brent Jensen / Karen Jensen / / / Position drug information consultant / Governor / / Product Finasteride / Tamsulosin / Hytrin / Minipress / Flomax / Cardura / Avodart / Proscar / blood pressure regulation / / ProvinceOrState Colorado / / Technology alpha / / URL www.usask.ca/druginfo / http /
SocialTag |
Question: Should the combination of alpha-adrenergic blockers and 5-alpha reductase inhibitors be used to treat benign prostatic hyperplasia